Levothyroxine replacement dose for primary hypothyroidism decreases with age

Rosenbaum, Robert L.; Barzel, Uriel S.; Rosenbaum, R L; Barzel, U S
January 1982
Annals of Internal Medicine;Jan82, Vol. 96 Issue 1, p53
Academic Journal
journal article
We studied 23 elderly (other than 65) and 44 younger ambulatory adult patients with primary hypothyroidism to ascertain the dose of levothyroxine needed for complete replacement in relation to age. The elderly patients (average age, 75.7 years) needed an average 118 microgram/d whereas the younger patients (average age, 48.1 years) needed 158 microgram/d. The data indicate that thyroxine requirement may decrease continuously with age. This decrease probably reflects the progressive decrease in thyroxine degradation rate that occurs with age.


Related Articles

  • Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values inn hypothyroid patients receiving thyroxine: a case for 'tissue thyrotoxicosis.' Jennings, P.E.; O'Malley, B.P.; Griffin, K.E.; Northover, B.; Rosenthal, F.D. // British Medical Journal (Clinical Research Edition);12/15/1984, Vol. 289 Issue 6459, p1645 

    Examines the effects of thyroxine replacement therapy on patients with hypothyroidism. Reduction of systolic time intervals; Correlation between serum thyroxine concentration and tissue thyrotoxicosis; Significance of triiodothyronine concentration.

  • Thyroxine replacement treatment and osteoporosis. Franklyn, J.A.; Sheppard, M.C. // BMJ: British Medical Journal (International Edition);3/17/90, Vol. 300 Issue 6726, p693 

    Examines the relationship between reduced thyroxine for hypothyroidism treatment and osteoporosis. Consideration of thyrotoxicosis as a risk factor for osteoporosis; Reduction of thyroid stimulating hormone concentrations; Increase of the risk for osteoporosis.

  • Lesson of the Week: Acute adrenal crisis precipitated by thyroxine. Fonseca, V.; Brown, R.; Hochhauser, D.; Ginsburg, J.; Havard, C.W.H. // British Medical Journal (Clinical Research Edition);5/3/1986, Vol. 292 Issue 6529, p1185 

    Examines the precipitation of an acute adrenal crisis during thyroxine replacement in patients with primary hypothyroidism. Effects of continuation of thyroxine to a classical adrenal crisis; Response of cortisol to stress; Prevention of the development of a fatal acute adrenal crisis.

  • Thyroxine: anatomy of a health scare. Faasse, Kate; Cundy, Tim; Petrie, Keith // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/2/2010, Vol. 340 Issue 7736, p20 

    The article discusses the adverse reaction reports relating to the new formulation of thyroxine replacement therapy Eltroxin introduced by GlaxoSmithKline in New Zealand. According to some reports, the new formulation of the Eltroxin brand resulted in a change in the tablets' inert ingredients...

  • Thyroid hormone treatment for lithium-induced thyroid dysfunction in mood disorder. Ramasubbu, Rajamannar // Journal of Psychiatry & Neuroscience;Mar2003, Vol. 28 Issue 2, p134 

    Discusses the use of thyroxine supplementation (T4) for treating lithium-induced hypothyroidism in patients with mood disorders. Role of T4 in augmenting the effects of mood stabilizers; T4 dosage; Risks associated with T4 supplementation.

  • The evaluation of transient hypothyroidism in patients diagnosed with congenital hypothyroidism. PELTEK KENDİRCİ, Havva Nur; AYCAN, Zehra; SAĞSAK, Elif; KESKİN, Melikşah; ÇETİNKAYA, Semra // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 4, p745 

    Background/aim: Congenital hypothyroidism (CH) is divided into two groups as 'permanent' and 'transient'. We aimed to determine the rate of transient and permanent congenital hypothyroidism of the newborns referred to our clinic. Materials and methods: Of the newborns who were referred to our...

  • Treatment with T4 based on body weight improved hypothyroidism markers.  // Endocrine Today;2/10/2008, Vol. 6 Issue 2, p30 

    The article discusses research being done on the use of body weight thyroxine with free T4 in treating patients with central hypopituitarism. It references a study published in a 2007 issue of “Journal of Clinical Endocrinology & Metabolism.” The study shows that treatment with body...

  • Clinico-Therapeutics of Hypothyrodism in a Labrador dog. Ghodasara, S. N.; Savsani, H. H.; Kalaria, V. A.; Bhadaniya, A. R.; Odedra, M. D. // Intas Polivet;Jul-Dec2013, Vol. 14 Issue 2, p432 

    A four and half year old Labrador male dog was presented with skin ailment. Detailed clinical examination revealed anorectic, dull, unresponsive and having generalised skin infection with hair loss /alopecia. The biochemicals profile revealed decrease in T3 and T4 level. Based on history,...

  • Correction: History and Future of Treatment of Hypothyroidism.  // Annals of Internal Medicine;3/1/2016, Vol. 164 Issue 5, p376 

    There is an error in a recent article. The last sentence of the section titled "L-Thyroxine Monotherapy Fails to Restore All Markers of Hypothyroidism" should read "new technology is needed to allow for steady delivery of L-triiodothyronine" (it currently reads "… for steady delivery of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics